Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

U.S.$) 2009 2008 2009 2008 ------------------------------------------------------------------------- GAAP net loss $ (15,633) $ (76,963) $ (22,868) $ (741,176) Interest expense on long-term debt 9,068 10,639 38,039 44,490 Income tax expense (recovery) (1,532) (2,577) 6,037 (12,892) Depreciation and Amortization 9,460 9,327 37,026 38,174 ------------------------------------------------------------------------- EBITDA 1,363 (59,574) 58,234 (671,404) Adjustments: Non-recurring revenue, net of license fees(a) (53) (352) (25,556) (910) Restructuring related charges(b) (309) 1,583 3,820 10,407 In-process and non-recurring research and development charges(c) 500 313 1,866 3,438 Non-recurring supply/distribution agreement termination costs(b) - - - 500 Stock-based compensation(d) 408 458 1,579 2,439 Litigation expenses(g) 684 177 3,297 2,670 Foreign exchange loss (gain)(h) 385 1,032 1,612 (540) Investment and other income 196 498 122 (1,255) Write-downs of investments and other long-lived assets(i) 3,090 12,247 3,090 24,870 Write-down of goodwill(i) - 50,285 - 649,685 Write-downs and other non-recurring deferred financing costs(f) - 3,665 643 17,209 Non-recurring char
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC ... announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd. ... one of its proprietary human-derived CPP sequences and a ... of NFkB signalling even if administered when the BBB ... blood brain barrier (BBB) in mice was studied and ...
(Date:4/20/2015)... 20, 2015   Meditope Biosciences, Inc ., a ... technology, today announced presentation of data demonstrating the use ... antibody-drug conjugates (ADCs). The data were presented in an abstract ... 18-22 in Philadelphia . ... point to the many commercial applications that may be ...
(Date:4/20/2015)... 2015 Whitehouse Laboratories is pleased and ... most recent Food and Drug Administration (FDA) inspection and ... five day, GMP compliance inspection, as based upon 21CFR ... through April 6th and was granted NAI (no action ... the strict Good Manufacturing Practice (GMP) quality system required ...
(Date:4/17/2015)... April 17, 2015  Centrillion Technologies, a ... grant from the National Human Genome Research ... Health (NIH). The grant will help fund ... development of breakthrough genomic technologies, including phased ... substrates. Centrillion has been developing this transformative ...
Breaking Biology Technology:Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3
... NEW YORK, Feb. 4 Emisphere Technologies, Inc.,(Nasdaq: ... unique and,improved delivery of therapeutic molecules using its eligen(R) ... BIO CEO & Investor,Conference on February 12, 2008 at ... V. Novinski, President and Chief Executive Officer of,Emisphere, will ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, California, ... through its wholly owned subsidiary Jade,Pharmaceutical Inc. ... with Jade, engages in the development, manufacture ... diagnostic products. The,Company announced today that JPI,s ...
... - Conference Call Scheduled for 5 February 2008, 09:00 ... ... BRISBANE, Australia, Feb. 4 Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq: ... to acquire privately-held U.S.,oncology company CellGate, Inc. The CellGate acquisition ...
Cached Biology Technology:Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12 2AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities 2Progen Expands Drug Development Pipeline Through Acquisition of CellGate 2Progen Expands Drug Development Pipeline Through Acquisition of CellGate 3Progen Expands Drug Development Pipeline Through Acquisition of CellGate 4Progen Expands Drug Development Pipeline Through Acquisition of CellGate 5
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2
... a chronic swelling condition that can appear after ... million breast cancer survivors. Although lymphedema can cause ... chest, there is no national standard of diagnosis ... leading the American Lymphedema Framework Project (ALFP), a ...
... On the first anniversary of the American Recovery ... the nation,s research universities today provided nearly 100 examples ... is paying outsize short- and long-term dividends for the ... ARRA, $21.5 billion is allocated for research and science ...
... State University graduate students teaching introductory biology labs are ... engage their students in critical thinking, and even craft ... a Graduate Teacher Training Program supported by a portion ... university has received. The training program is operated by ...
Cached Biology News:Researchers develop standard of care for breast cancer survivors with lymphedema 2Universities highlight benefits of stimulus research funding 2Universities highlight benefits of stimulus research funding 3Oregon State trains graduate students to be better TAs 2Oregon State trains graduate students to be better TAs 3Oregon State trains graduate students to be better TAs 4
Human PLUNC MAb (Clone 252512)...
... to GRASP1 ( Abpromise for ... Antigen: Synthetic peptide corresponding to ... terminal region of rat GRASP1, conjugated ... Entrez GeneID: 56850 ...
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
Biology Products: